PATANJALI2022-10-012022-12-31in-bse-fin:OneOperatingExpenses01Member PATANJALI2022-10-012022-12-31in-bse-fin:FourOperatingExpenses01Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentRevenue01Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentRevenue02Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentRevenue03Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentRevenue04Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentRevenue01Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentRevenue02Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentRevenue03Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentRevenue04Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentResults01Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentResults02Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentResults03Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentResults04Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentResults01Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentResults02Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentResults03Member PATANJALI2022-10-012022-12-31in-bse-fin:FourReportableSegmentResults04Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentAssets01Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentAssets02Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentAssets03Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentAssets04Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentLiabilities01Member PATANJALI2022-12-31in-bse-fin:OneReportableSegmentLiabilities01Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentLiabilities02Member PATANJALI2022-12-31in-bse-fin:OneReportableSegmentLiabilities02Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentLiabilities03Member PATANJALI2022-12-31in-bse-fin:OneReportableSegmentLiabilities03Member PATANJALI2022-10-012022-12-31in-bse-fin:OneReportableSegmentLiabilities04Member PATANJALI2022-12-31in-bse-fin:OneReportableSegmentLiabilities04Member PATANJALI2022-10-012022-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PATANJALI2022-10-012022-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member PATANJALI2022-10-012022-12-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member PATANJALI2022-10-012022-12-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares PATANJALI 2022-04-01 2023-03-31 2023-01-17 INR Lakhs Third quarter Multi segment 2022-10-01 2022-12-31 Unaudited Standalone 79266402000.00 371141000.00 79637543000.00 64723739000.00 7970802000.00 -3215972000.00 727901000.00 189378000.00 427487000.00 5379555000.00 76202890000.00 3434653000.00 0.00 3434653000.00 839896000.00 -97124000.00 742772000.00 0.00 2691881000.00 0.00 0.00 0.00 0.00 2691881000.00 -19725000.00 2672156000.00 0.00 0.00 723837000.00 2 7.46 7.46 0.00 0.00 7.46 7.46 1. The Audit Committee has reviewed the above results and the Board of Directors has approved the above results and its release at their respective meetings held on January 25, 2023. The Statutory Auditors of the Company have carried out limited review of above financial results for the quarter and Nine months ended December 31, 2022. 2. Pursuant to Business Transfer Agreement, as amended, entered with Patanjali Ayurved Limited (PAL), with effect from July 1, 2022 (“Acquisition Date”), the Company has acquired Food Retail Business (‘Food Retail Business Undertaking”) as a going concern on a Slump Sale basis for a cash consideration of Rs. 69,000 Lakh. Accordingly, on acquisition date, all the assets acquired including intangible assets identified aggregating to Rs. 73,733.67 Lakh are accounted at fair value in accordance with IND AS 103 on Business Combinations, differential amount of Rs. 3,646.68 Lakh after considering effects of deferred tax liabilities are credited to Capital Reserve. Subsequent to in-principal approval of PAL’s lenders, No Objection Certificate from Lead Banker in respect of said transfer has been received and from other lenders the same is being obtained. 3. The Company has issued 6,61,53,846 equity shares of face value of Rs. 2 each for cash at an issue price of Rs. 650 (including share premium of Rs. 648 per share) per equity shares aggregating to Rs. 4,30,000 Lakh by the way of further public offering (FPO). On April 8, 2022, these equity shares of the Company have been listed on BSE Limited and National Stock Exchange of India Limited. Post allotment of aforesaid shares, the paid up equity share capital of the Company have been increased to Rs. 7,238.37 Lakh divided into 36,19,18,552 equity shares (net of treasury shares) of face value of Rs. 2 each from Rs. 5,915.29 Lakh divided into 29,57,64,706 equity shares (net of treasury shares). Issue related expenses has been adjusted against Security Premium. 4. The utilisation of proceeds of FPO is summarised below :- Rs. in Lakh Objects of the issue as per prospectus Amount to be utilised as per prospectus Revised Amount to be utilised as per Board Approval Utilisation up to December 31, 2022 Unutilised amount as on December 31, 2022 Repayment and/ or prepayment of borrowings from consortium of lenders and Patanjali Ayurved Limited, one of our Promoters, in full or part, availed by Company 2,66,382.52 2,66,382.52 2,66,382.52 - Funding incremental working capital requirements of Company 59,342.48 59,342.48 59,342.48 - General corporate purposes 89,644.65 95,976.44* 95,975.81 0.63# Issue related expenses 14,630.35 8,298.56* 5,707.19 2,591.37# Total 4,30,000.00 4,30,000.00 4,27,408.00 2,592.00 * The Board of Directors of the Company on April 8, 2022, approved the revised estimate of issue expenses from Rs. 14,630.35 Lakh to Rs. 8,298.56 Lakh. The difference amount of Rs. 6,331.79 Lakh has been earmarked by the Company for the general corporate purpose. General corporate purpose also includes repayment of borrowings. # The FPO proceeds which were unutilised as at December 31, 2022 are parked in FPO Monitoring Agency Bank account and in FPO public issue account. Multi segment 2022-04-01 2022-12-31 Unaudited Standalone 236517320000.00 2067682000.00 238585002000.00 189293562000.00 24555048000.00 -2507325000.00 2007845000.00 2152282000.00 1162981000.00 13624895000.00 230289288000.00 8295714000.00 0.00 8295714000.00 2251591000.00 -183209000.00 2068382000.00 0.00 6227332000.00 0.00 0.00 0.00 0.00 6227332000.00 -30173000.00 6197159000.00 0.00 0.00 723837000.00 2 17.25 17.25 0.00 0.00 17.25 17.25 Other Expenses 5379555000.00 Other Expenses 13624895000.00 Food Products and Others 15700821000.00 Oils & Vanaspati 60665138000.00 Seed Extraction 6894494000.00 Wind Turbine Power Generation 106156000.00 Food Products and Others 45422246000.00 Oils & Vanaspati 183940830000.00 Seed Extraction 17255709000.00 Wind Turbine Power Generation 444821000.00 83366609000.00 247063606000.00 4100207000.00 10546286000.00 79266402000.00 236517320000.00 Food Products and Others 1622113000.00 Oils & Vanaspati 1767900000.00 Seed Extraction 154736000.00 Wind Turbine Power Generation 9674000.00 Food Products and Others 8583947000.00 Oils & Vanaspati -586020000.00 Seed Extraction 644294000.00 Wind Turbine Power Generation 158383000.00 3554423000.00 8800604000.00 189378000.00 2152282000.00 -69608000.00 -1647392000.00 3434653000.00 8295714000.00 Food Products and Others 26752117000.00 Oils & Vanaspati 47705149000.00 Seed Extraction 9854387000.00 Wind Turbine Power Generation 3122499000.00 87434152000.00 50139868000.00 137574020000.00 Food Products and Others 10903612000.00 Oils & Vanaspati 21525384000.00 Seed Extraction 721457000.00 Wind Turbine Power Generation 0.00 33150453000.00 8570420000.00 41720873000.00